In focus
Latest feed
New Mesothelioma Drug Turns Cancer’s Own Defenses Against It
Rubedo Life Sciences Launches First‑in‑Human GPX4 Modulator Trial for Hair Loss
Vera Therapeutics' Trutakna Achieves Landmark Success in Phase 3 Trial for IgA Nephropathy
Roivant’s Mosliciguat Shines in Phase 2, Sending ROIV Shares Toward All‑Time High
